A detailed history of Allspring Global Investments Holdings, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 2 shares of ALXO stock, worth $3. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$3
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1.81 - $8.13 $3 - $16
2 New
2 $0
Q1 2023

Apr 13, 2023

BUY
$4.52 - $11.71 $7,851 - $20,340
1,737 Added 13.37%
14,724 $66,000
Q4 2022

Jan 23, 2023

SELL
$9.51 - $12.95 $561 - $764
-59 Reduced 0.45%
12,987 $0
Q3 2022

Oct 26, 2022

SELL
$8.23 - $15.14 $111,253 - $204,662
-13,518 Reduced 50.89%
13,046 $124,000
Q2 2022

Jul 25, 2022

BUY
$5.89 - $19.46 $156,461 - $516,935
26,564 New
26,564 $214,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $74.6M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.